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Introduction: The advent of “personalized medicine” has been driven by technological advances 
in genomics. Concentration at the subcellular level of a patient’s cancer cells has meant inevi-
tably that the “person” has been overlooked. For this reason, we think there is an urgent need 
to develop a truly personalized approach focusing on each patient as an individual, assessing 
his/her unique mental dimensions and tailoring interventions to his/her individual needs and 
preferences. The aim of this study was to develop and test the psychometric properties of the 
ALGA-Breast Cancer (ALGA-BC), a new multidimensional questionnaire that assesses the breast 
cancer patient’s physical and mental characteristics in order to provide physicians, prior to the 
consultation, with a patient’s profile that is supposed to facilitate subsequent communication, 
interaction, and information delivery between the doctor and the patient.
Methods: The specific validation processes used were: content and face validity, construct 
validity using factor analysis, reliability and internal consistency using test–retest reliability, 
and Cronbach’s alpha correlation coefficient. The exploratory analysis included 100 primary 
breast cancer patients and 730 healthy subjects.
Results: The exploratory factor analysis revealed eight key factors: global self-rated health, 
perceived physical health, anxiety, self-efficacy, cognitive closure, memory, body image, and 
sexual life. Test–retest reliability and internal consistency were good. Comparing patients with 
a sample of healthy subjects, we also observed a general ability of the ALGA-BC questionnaire 
to discriminate between the two.
Conclusion: The ALGA-BC questionnaire with 29 items is a valid instrument with which to 
obtain a patient’s profile that is supposed to help physicians achieve meaningful personalized 
care which supplements biological and genetic analyses.
Keywords: personalized medicine, patient–physician communication, questionnaire  validation, 
patient preferences
Introduction
According to the personalized medicine approach, appropriate and optimal therapies 
are mainly based on the analysis of the patient’s genome. Medicine, however, is broader 
than subcellular characteristics, and the patient as a person is the pivotal focus. Focus on 
the diverse consequences associated with the illness itself is critical to optimal patient 
care.1,2 In particular, along with assessing his/her biological and clinical characteris-
tics, it is important to give attention to each patient as an individual, assessing unique 
mental dimensions and tailoring interventions to them. According to this vision, the 
patient should not only be evaluated organically and technically, but also at the psycho-
logical, cognitive, emotional, and social levels which are often significantly disrupted 
when receiving a diagnosis of serious life-threatening diseases such as cancer. A main 
Breast Cancer: Targets and Therapy 2015:7submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
134
gorini et al
component of this new approach to personalized medicine 
should include optimization of communication between the 
physician and the patient3 which is fundamental to realizing a 
shared decision-making model. In order to achieve effective 
communication, to provide understandable information, and 
to increase patient understanding so that shared decision mak-
ing can occur, it is necessary for physicians to have consistent 
knowledge about the individual patient they are working with. 
When a physician is knowledgeable about the patient’s physical, 
psychological, emotional, social, and cognitive status, it is eas-
ier to format the structure of the communication/relationship. 
In studying the benefits associated with high-quality patient/
physician communication, Detmar et al4 researched the poten-
tial value of communication during medical visits, finding that 
when the physician was provided with health-related quality 
of life data from the patient, effective communication was 
facilitated and more relevant issues were discussed. Other 
studies have shown the benefits of quality patient/physician 
communication, reporting that women have been found to feel 
less anxious and depressed when they feel as if their physician 
had offered adequate information about their health status.5 In 
addition, women who have positive experiences with physi-
cians and receive satisfactory information are less likely to 
refuse conventional medicine and experience less decisional 
conflict, regret, and psychological distress than the others.6
There is a need for a reliable, ready-to-use patient-profiling 
tool to be used before the first encounter with a patient which 
sets the style and informs the communication tone, language, 
and content of all subsequent doctor–patient discussions. Such 
a tool will be based on a new multidimensional questionnaire 
that assesses the breast cancer patient’s physical and mental 
characteristics in order to provide physicians, prior to the 
consultation, with a patient’s profile that is supposed to facili-
tate subsequent communication, interaction, and information 
delivery between the doctor and the patient.
Two main benefits of constructing a validated question-
naire and a subsequent patient-profiling tool can be identified. 
On the clinical side, it will serve to optimize information 
delivery from doctors to patients: doctors, having a patient 
profile, can rapidly adjust the content and the level of verbal 
information to the patient’s needs and level of  understanding. 
On the research side, the same tool can be used to auto-
matically identify, through advanced algorithms, the possible 
clinical trials in which the patient could be enrolled.
aims
The present study was aimed to develop and validate a new 
questionnaire for breast cancer patients, which qualitatively 
and quantitatively assesses the overall physical, psychologi-
cal, and cognitive status of the patient after the diagnosis. 
Differently from the existing questionnaires, this question-
naire is not intended to be standalone, but to be the core of the 
future planned computerized profiling tool that will automati-
cally analyze the individual patients’ answers to generate a 
patient’s profile. Such a profile should then help the physician 
to tailor his/her communication style and content in order to 
meet the patient’s needs and preferences.
This questionnaire is intended to be: 1) short, simple, and 
user-friendly; 2) psychometrically sound with good validity 
and reliability; 3) useful both in research and clinical prac-
tice; 4) sufficiently sensitive to reliably quantify physical, 
psychological, and cognitive characteristics of breast cancer 
patients; and 5) suitable to be administered online so that the 
patient’s answers can be immediately analyzed by the future 
dedicated profiling tool. The new questionnaire has been 
named ALGA-Breast Cancer (ALGA-BC) and is reported, 
in English and Italian, in Table 1.
Once validated in breast cancer patients, the ALGA-BC 
questionnaire will be tested in a sample of healthy subjects, 
in order to verify if the same factors can be found in the two 
samples, and if their results are similar or not.
Methods
The development and validation of the ALGA-BC ques-
tionnaire occurred in two separate phases (the development 
procedure and the validation procedure) involving a sample 
of 100 breast cancer patients. The study was approved by 
the ethical committee of the hospital were the study was 
conducted.
The method used for the two steps is described in detail 
below.
subjects
Patients recruited for the development and validation of the 
new questionnaire were drawn from the breast cancer unit of 
the European Institute of Oncology in Milan, Italy. In order 
to have a homogenous sample, only the women aged between 
18 and 70 years diagnosed with primary breast cancer who 
had undergone radical surgery between January and October 
2014 were consecutively asked to participate in the study. 
Patients with recurrent breast cancer or with overt psychiatric 
illness which would interfere with the measurement of psy-
chological variables were excluded from the study (Table 2 
for the demographic characteristics of the two samples). The 
sample size of 100 was determined accordingly to Rattray 
and Jones7 and Terwee et al.8 Patients included in the study 
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Table 2 Demographic characteristics of the two samples (breast 
cancer patients versus healthy subjects)
Patients Controls
n % n %
age
 ,20 years 1 1 4 1
 20–24 years 0 0 72 10
 25–29 years 1 1 103 14
 30–39 years 13 13 172 24
 40–49 years 29 29 171 23
 50–60 years 35 35 150 21
 .60 years 20 20 58 8
Marital status
 single 7 7 214 29
 Unmarried partner 7 7 111 15
 Married 67 67 357 49
 separated or divorced 12 12 42 6
 Widow 7 7 6 1
educational level
 elementary school 10 10 0 0
 Middle school 13 13 6 1
 high school 52 52 71 55
 University 23 23 398 10
 PhD/specialization 2 2 255 35
were planned to answer the questionnaire before their first 
encounter with the medical oncologist.
A sample of 730 healthy volunteers were randomly 
selected from the general population. To be included in 
study, healthy subjects must have been aged between 18 
and 70 years and to be healthy (no acute or chronic illness at 
the moment of the evaluation and no past history of cancer). 
Healthy subjects also filled out the questionnaire using online 
survey software and were tested during the same period as 
cancer patients.
Phase 1: development of the instrument 
and item pool
The aim of the development phase was to build a questionnaire 
which included both physical and mental aspects that can play 
a relevant role in coping with the diagnosis of cancer, or can be 
altered as a result of receiving the diagnosis. In particular, we 
wanted to investigate the perceived health and physical state, 
as well as the psychological and cognitive aspects essential 
to creating a broad personal patient profile.
Content validity
To achieve content validity and identify representative 
and relevant items, a literature review was conducted in 
 MEDLINE, searching for validated questionnaires assess-
ing physical, psychological, and cognitive aspects related to 
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breast cancer. In addition, results from informal interviews 
with breast cancer patients and medical oncologists were used 
to delineate the most relevant elements which emerge after a 
cancer diagnosis, and how they influence the patient’s daily 
life and the way in which she interacts with her physician 
and elaborates the information provided.
The research group, consisting of experienced psycholo-
gists knowledgeable in psychometrics and medical oncolo-
gists, created the initial pool of items by using questions 
carefully selected from a number of validated psychological 
questionnaires (see the next paragraph) on the basis of their 
own knowledge and the patient interviews. The items were 
thereafter evaluated by an expert panel consisting of clinical 
and cognitive psychologists, medical oncologists, nurses, and 
breast cancer patients referred for treatment at the European 
Institute of Oncology. The expert panel was asked to suggest 
additional items for the item pool if they found any domains 
or concerns that were not covered.  Fifteen randomly selected 
patients were encouraged to suggest new questions if they 
thought there were concerns missing at the time of data 
 collection. During the initial and validation phases, patients 
were also asked for comments on the questionnaires’ read-
ability and  understandability. Patients who participated in the 
informal interviews were the same who were asked to suggest 
new questions and to evaluate the existing ones. These patients 
were then excluded from the final questionnaire testing.
As a result of this consultation, three questions about 
sexual life were added to the original pool of items. The expert 
panel also gave recommendations for changes to improve 
clarity and the logical order of the items. The development 
process resulted in 38 questions about physical and mental 
status selected, though mostly modified and reformulated, 
from the following existing and validated questionnaires: 
European Organization for Research and Treatment of 
Cancer Quality of Life Questionnaire – Core (EORTC QLQ-
C30);9 European Organization for Research and Treatment 
of Cancer Quality of Life Questionnaire – Breast (EORTC 
QLQ-BR23);10 Center of Epidemiologic Studies Depression 
Scale (CES-D);11 Everyday Memory Questionnaire – Revised 
(EMQ-R);12 General Self-Efficacy Scale (GSE);13 and Need 
for Cognitive Closure  Scale.14
As a final step, the content validity of the questionnaire 
was evaluated using the content validity index (CVI). A first 
draft of the instrument in the form of CVI was sent to 20 psy-
chologists and clinical oncologists who were asked to answer 
using a four-point scale ranging from 1 to 4 (not relevant 
to highly relevant). According to recommendations in the 
 literature, a level of 0.80 or greater was used as a  criterion for 
demonstrating content validity.15,16 Items receiving a rating 
less than 0.80 were revised.
Face validity
To determine the face validity, patients were given an evalu-
ation form assessing the questionnaire in terms of feasibility, 
readability, and consistency of style and formatting. The 
patients’ preference for completing the questionnaire using 
an electronic device (iPad) instead of paper-and-pencil sup-
port was also assessed.
Phase 2: construct validity and internal 
consistency reliability
Construct validity answers the question of whether or not 
the items of an instrument consistently, and with sufficient 
precision, measure the construct they are supposed to 
measure.17,18
The sample for factor analysis included 100 Italian women 
operated for newly diagnosed primary breast cancer who were 
able to respond to the questionnaire and who expressed their 
willingness to participate in the study. Patients filled out the 
questionnaire on an iPad after signing the informed consent 
form and immediately before their first encounter with the 
medical oncologist, during which they received the proposal 
for the subsequent courses of treatment, based on targeted 
chemotherapy and/or endocrine therapy and/or radiotherapy. 
When completing the questionnaire, patients were not aware 
of their final (post-surgical) diagnosis. A psychologist was in 
attendance to answer any questions from the patient during 
the questionnaire completion.
Most of the questions referred to the last 2 or 4 weeks 
(as indicated in the questionnaire), except those regarding 
“state- trait anxiety”, “self efficacy”, and “cognitive closure” 
which are supposed to be almost stable along time (Figure 1 
for a flowchart of the data collection).
In a future study, the results will be automatically processed 
according to a scoring system and then forwarded by Internet 
to the physician ahead of the interview with the patient.
In order to assess the factor structure of the core item 
set, principal components analysis with varimax rotation 
was performed. A principal factors method, which entails 
no distributional assumptions, was used to fit the common 
factor model to the data. A rotated principal factors extrac-
tion was performed on all items to estimate the number of 
factors to retain.19–22
The scree plot of ordered eigenvalues of a correlation 
matrix was used to decide the appropriate number of factors 
extracted. Items were eliminated based on low factor loading. 
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Internal consistency analysis was performed separately 
on items comprising each of the factors identified evaluating 
Cronbach’s alpha.
To evaluate the goodness of fit between the models and 
data, we used fit indices, including the standardized root-
mean-square residuals, comparative fit index, and root mean 
square error of approximation (RMSEA) that indicates the 
amount of unexplained variance. A sufficient model fit was 
defined as the standardized root-mean-square residual of 
0.08 or less, comparative fit index of 0.90 or greater, and 
RMSEA of 0.06 or less.
Predictions for discriminative and divergent validity 
were made based on a literature review. Differences were 
evaluated between patient age groups, level of education, 
marital status, the presence of children (ie, if a woman had 
ever given birth to any children), a past history of cancer 
diseases, and the presence of past or present psychological 
treatments. One-way analysis of variance tests were used to 
investigate the relationships between scores and the above 
sociodemographic variables. Residuals from full models, 
investigating factor variations, were checked to assess normal 
distribution.
Finally, we checked if the scores of factors obtained 
considering cancer cases were significantly different between 
patients and healthy subjects (individuals with no history 
of cancer diseases who completed the same version of the 
questionnaire) and also if factors obtained analyzing the 
controls’ responses separately were different from the ones 
obtained including only cancer patients.
Results
Patient sociodemographics
Data were analyzed using the statistical software SAS, 
 version 9.2.
Forty-four percent of the 100 patients included in the 
study were aged less than 50 years. Most of the subjects were 
married or lived with a partner (74%), had children (84%), 
and had attended high school (75%). Sixteen of them had 
received or were receiving psychological treatment at the 
moment of evaluation. For 90 of them it was the first diagnosis 
of cancer, while ten had already had a previous cancer.
The sample of healthy subjects included 730 volunteers, 
who completed the questionnaire online, and of whom 293 
(40%) were women. The majority of the controls (n=522, 
72%) were 50 years old or older (14% were young adults, 
30 or less years old), had a university degree (n=653, 45%), 
and were married or lived with a partner (n=468, 64%). Half 
of the sample had children, and a quarter (25%, n=186) had 
Literature review
Informal interview with 15
randomly selected breast cancer
patients and medical oncologists
Questionnaire development
(35 questions)
Evaluation by an expert panel
and 15 randomly selected patients
38 items
Content and face validity
check
Construct validity and
internal consistency testing
(100 breast cancer patients
and 730 healthy subjects)
Factor analysis resulted in
29 questions grouped in
eight factors
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Figure 1 The research process starting from the development of the questionnaire 
to data collection and analysis.
ALGA-BC
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Cognitive
closure
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Self
efficacy
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Anxiety
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Global self-
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Factor 8
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Body
image
Figure 2 The eight factors included in the alga-Breast Cancer (alga-BC) 
questionnaire.
Loading magnitudes were considered unacceptably low if 
they were less than 0.50.23
Next, scores were calculated for each participant by sum-
ming the item scores identified for each factor and dividing 
by the total number of items.
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asked at least once in their life for psychological counseling 
(Table 2 for a summary of the demographic characteristics 
of the two samples).
Content validity
The total ALGA-BC scale showed good content validity 
(CVI =0.96).
Face validity
Ninety-six percent of respondents found the questions easy 
to answer and clearly understandable. They also found the 
appearance and layout acceptable, each parameter being 
evaluated at 3 or 4 on a Likert scale of 1–4.
After this first evaluation phase, all the 38 initial items 
were included in the questionnaire.
Construct validity
The Bartlett’s test of sphericity,9,24,25 used to verify the 
assumption that variances are equal across groups or samples, 
was highly significant (P=0.006), indicating that the distri-
bution of data met the psychometric criteria for exploratory 
factor analysis to proceed. The scree test of eigenvalues 
plotted against factors suggested an eight-factor solution, 
explaining 98% of the variance. The measure of sampling 
adequacy is good (0.76).
We obtained satisfactory Cronbach’s alphas, greater than 
0.70 (for factor 3), and higher than 0.90 for factors 1 and 7. 
Deleting an item from the analysis would not substantially 
improve the overall Cronbach’s for any scale. These values 
indicate a good reliability of the test.
Finally, an excellent average inter-item correlation 
greater than 0.40 was found.
Substantive interpretation of the pattern of factor loadings 
resulted in the labels “global self-rated health”, “perceived 
physical health”, “anxiety”, “self efficacy”, “cognitive 
 closure”, “memory”, “body image”, and “sexual life”, 
 keeping 29 items out of the initial 38.
The eight factors are explained as follows:
•	 Factor 1: “global self-rated health”. This factor includes 
two items that focus on how patients consider their health 
status in general and relatively to their age.26 Measures 
of global self-rated health have been proved to have 
significant clinical value in cancer care.27
•	 Factor 2: “perceived physical health” (eight items). These 
items focus on fatigue, weakness, physical limitations, 
pain, and sleep problems concomitant to the illness. It 
has been observed that patients who report more per-
ceived health problems after a cancer diagnosis have 
more posttraumatic stress symptoms and a compromised 
health-related quality of life.28,29
•	 Factor 3: “anxiety”. These two items investigate the 
state anxiety (anxiety about a specific event) versus trait 
anxiety (anxiety as a personal characteristic) perceived by 
patients.30 Anxiety associated with cancer may increase 
feelings of pain, cause nausea and vomiting, and interfere 
with the ability to sleep and with the patient’s quality of 
life in general. It can also alter the patient’s cognitive 
abilities, such as memory and attention, reducing her abil-
ity to understand information given by the physician.31–33 
In cancer patients, feelings of anxiety may increase or 
decrease at different times so the variation between the 
reference point (usual level of anxiety) and the actual 
level of anxiety is important to understanding the real 
status of the patient and how it varies along time.
•	 Factor 4: “self efficacy” (six items). This factor refers 
to “a broad and stable sense of personal competence to 
deal effectively with a variety of stressful situations”.34 
Individuals possessing a high level of self-efficacy are 
optimistic and self-confident in their own coping abilities 
when confronted with life stressors such as a diagnosis of 
cancer. A strong sense of self-efficacy was found to be 
generally correlated with better health. On the contrary, 
a low sense of self-efficacy is associated with depression 
and anxiety.35,36 This makes the dimension of self-efficacy 
crucial in the context of cancer care.
•	 Factor 5: “cognitive closure”. This factor includes three 
items investigating the individual’s tendency to seek 
out information when they have to make a decision.37,38 
Cognitive closure is a dispositional construct that is 
referred to as a latent variable manifested through several 
different aspects including the desire for predictability, 
the discomfort with ambiguity, and close-mindedness. 
In medical contexts, cognitive closure is related to the 
patient’s preference for the amount of information she 
wishes to receive about illness, treatment, etc. The assess-
ment of cognitive closure might thus assist the physician 
in his/her decision on how much information should be 
best provided in order for the patient to make an informed 
choice.
•	 Factor 6: “memory”. This factor is made up of four items 
that explore the mnestic abilities of patients.  Difficulties 
in the ability to remember, think, and concentrate are 
often reported by breast cancer patients as a conse-
quence of treatment or because of the excessive level 
of stress and worries.39 Next to the immediate impact of 
impairments in memory on the quality of life, memory 
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and concentration problems might also result in the 
patient’s lowered chance of actively participating in the 
medical and treatment-decision process.40 By previously 
informing the physician about the patient’s memory and 
attention problems, he/she might be able to adjust his/her 
way of communicating with the patient, thus ensuring 
shared decision making.
•	 Factor 7. In breast cancer patients, own body image may 
often change due to physical and psychological reasons, 
worsening women’s living.41 This factor (two items), 
called “body image”, investigates the level of acceptance 
and satisfaction the patient has regarding her body.
•	 Factor 8: “sexual life”. These two items ask for the recent 
general interest in sex and the extent to which patients 
have been sexually active. Investigating body image 
and sexual problems might be especially important in 
breast cancer patients, as these dimensions are strongly 
influenced by changes in female bodies resulting from 
surgery, radiotherapy, and chemotherapy.42
Finally, analyzing the sample of healthy subjects 
separately, the factor “anxiety” disappeared, while another 
factor, called “rumination”, emerged. Rumination indicates 
the tendency to compulsively focus attention on negative 
thoughts, instead of searching for solutions. Rumination 
is similar to worry except it focuses on bad feelings and 
experiences from the past, whereas worry is concerned 
with potential bad events in the future. Rumination is usu-
ally associated with anxiety and other negative emotional 
states.
Most of the questions referred to the last 2 or 4 weeks 
(as indicated in the questionnaire), except those regarding 
the “self efficacy” and the “cognitive closure” factors which 
are supposed to be almost stable along time.
Descriptive analyses of the scores by sociodemographic 
variables are provided in Table 3 with results of analysis of 
variance tests. As it can be observed, “perceived physical 
health” scores were significantly lower for “at least univer-
sity” than for high school (P=0.02), indicating that higher 
education contributes to a better perception of physical 
conditions; “anxiety” was significantly higher for mothers 
than for women without children (P=0.007); “memory”, 
“anxiety”, and “body image” scores were significantly 
higher for women with a history of psychological treat-
ments (P=0.015, P=0.003, and P=0.007, respectively); 
“global self-rated health” was borderline significantly 
better among the ten women with a history of cancer than 
in others; and “cognitive closure” looked greater at older 
ages (P=0.02).
Face validity
The questionnaire was considered easy to complete by 88% 
of subjects, and not too long by 72%, and the questions were 
judged pertinent by 85%.
Most of the subjects (87%) preferred to complete the 
questionnaire using an electronic device instead of using the 
paper-and-pencil version.
Test–retest reliability
The test–retest reliability of the instrument was calculated 
testing ten patients who repeated the questionnaire 2 weeks 
after the first administration. Test–retest reliability was 0.90 
(P,0.001).
Comparison between cancer patients  
and healthy subjects
Comparing the scores obtained by cancer patients with those 
from healthy subjects, we observed, as expected, significant 
differences in the following factor names: perceived physi-
cal health, self-efficacy, anxiety, cognitive closure, global 
self-rated health, sexual life, and rumination (Table 4). All 
these factors were higher in patients than controls, indicat-
ing that:
•	 patients perceive their physical health and sexual life as 
worse than healthy subjects do;
•	 patients experience a higher level of anxiety and a lower 
level of self-efficacy compared to healthy subjects;
•	 patients have higher cognitive closure compared to 
healthy subjects; and
•	 patients ruminate more than healthy subjects.
Discussion
The present study describes the development and validation 
of a disease-specific questionnaire for breast cancer patients 
which qualitatively and quantitatively assesses the overall 
physical, psychological, and cognitive status of the patient.
In order to cover the relevant areas of the influence of a 
cancer diagnosis on physical, psychological, and cognitive 
domains, items were chosen from discussions with patients, 
suggestions by experienced health care professionals, and 
literature review. Being asked to provide feedback on the 
topics included and the readability of the questions, both 
patients and physicians gave a significant contribution to the 
preparation of the questionnaire.
Content validity was guaranteed using the CVI method, 
which showed a good score for the total scale,15,16 while the 
lack of missing data from the 100 interviewed patients indi-
cates that the ALGA-BC questionnaire is relevant and not 
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Table 3 Median and interquartile range of factors
n Variable Median Lower quartile Upper quartile P-values
Marital status
  Married/living with partners 74 (74%) Physical state 2.88 2.38 3.38
Self-efficacy 3.00 2.17 3.67
Memory-attention 1.75 1.25 2.50
anxiety 6.00 4.50 7.00
Body image 2.00 1.50 3.00
Cognitive closure 3.00 2.00 3.33
gsrh 2.00 1.50 2.75
sexual life 3.00 2.00 4.00
  single/divorced/widow 26 (26%) Physical state 2.44 2.00 3.38
Self-efficacy 2.83 2.17 3.50
Memory-attention 2.00 1.25 2.75
anxiety 4.50 2.50 7.00
Body image 2.00 1.00 3.00
Cognitive closure 3.17 2.00 4.00
gsrh 2.00 1.50 2.25
sexual life 3.50 3.00 4.50
educational level
 high school 75 (75%) Perceived physical health 3.00 2.38 3.50 0.02
Self-efficacy 3.00 2.17 3.67
Memory 1.75 1.25 2.50
anxiety 6.00 3.50 7.00
Body image 2.00 1.00 3.00
Cognitive closure 3.00 2.00 3.67
gsrh 2.00 1.50 2.75
sexual life 3.00 2.00 4.00
 at least university 25 (25%) Perceived physical health 2.38 1.63 2.88
Self-efficacy 2.67 2.00 3.75
Memory 1.88 1.38 3.13
anxiety 5.25 4.50 6.50
Body image 2.00 1.50 2.75
Cognitive closure 2.67 2.17 3.83
gsrh 2.00 1.00 2.50
sexual life 3.00 2.50 4.00
Children
 Yes 84 (84%) Perceived physical health 2.88 2.25 3.50
Self-efficacy 3.00 2.17 3.67
Memory 1.75 1.25 2.75
anxiety 6.00 4.00 7.00 0.007
Body image 2.00 1.50 3.00
Cognitive closure 3.00 2.00 3.67
gsrh 2.00 1.50 2.75
sexual life 3.00 2.00 4.00
 no 16 (16%) Perceived physical health 2.31 1.56 3.38
Self-efficacy 2.75 2.17 3.58
Memory 2.00 1.25 2.50
anxiety 4.50 2.75 6.00
Body image 2.00 1.00 2.75
Cognitive closure 3.33 2.17 4.00
gsrh 1.63 1.25 2.25
sexual life 3.25 2.75 4.00
Psychological treatments
 Yes 16 (16%) Perceived physical health 3.06 2.00 3.75
Self-efficacy 3.00 2.42 3.75
Memory 2.75 1.75 3.13 0.015
anxiety 7.00 4.50 8.75 0.003
Body image 2.75 2.00 3.75 0.007
(Continued)
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Table 3 (Continued)
n Variable Median Lower quartile Upper quartile P-values
Cognitive closure 2.50 1.67 4.17
gsrh 2.25 1.50 2.63
sexual life 3.50 3.00 4.00
 no 81 (81%) Perceived physical health 2.75 2.13 3.38
Self-efficacy 2.83 2.17 3.67
Memory 1.75 1.25 2.50
anxiety 5.50 3.50 6.50
Body image 2.00 1.00 3.00
Cognitive closure 3.00 2.33 3.67
gsrh 2.00 1.50 2.75
sexual life 3.00 2.00 4.00
smoking
 Yes 14 (14%) Perceived physical health 2.75 2.13 3.63
Self-efficacy 3.00 2.67 3.50 0.002
Memory 1.75 1.25 2.50
anxiety 5.75 3.50 7.00
Body image 2.75 2.00 4.00
Cognitive closure 3.50 3.00 4.33 0.03
gsrh 2.00 1.50 2.75
sexual life 3.00 2.50 4.00
 no 76 (76%) Perceived physical health 2.88 2.00 3.50
Self-efficacy 3.17 2.17 3.83
Memory 2.00 1.25 2.75
anxiety 6.00 4.50 7.00
Body image 2.00 1.50 3.00
Cognitive closure 2.67 2.00 3.67
gsrh 2.00 1.50 2.75
sexual life 3.00 2.00 4.00
 ex-smoker (?) 10 (10%) Perceived physical health 2.75 2.63 3.00
Self-efficacy 2.00 1.50 2.33
Memory 1.50 1.25 2.50
anxiety 4.50 2.00 6.00
Body image 1.75 1.00 3.00
Cognitive closure 3.00 2.00 3.33
gsrh 1.88 1.50 2.25
sexual life 3.75 3.00 4.00
Physical activity
 Yes 36 (36%) Perceived physical health 2.69 2.00 3.38
Self-efficacy 3.08 2.00 3.75
Memory 2.00 1.50 2.75
anxiety 6.25 4.50 7.25
Body image 2.50 1.50 3.00
Cognitive closure 3.00 2.00 3.83
gsrh 1.88 1.25 2.38
sexual life 3.00 2.50 3.50
 no 64 (64%) Perceived physical health 2.88 2.25 3.63
Self-efficacy 2.83 2.17 3.50
Memory 1.75 1.25 2.50
anxiety 5.00 3.00 7.00
Body image 2.00 1.00 3.00
Cognitive closure 3.00 2.33 3.67
gsrh 2.00 1.50 2.75
sexual life 3.00 2.00 4.00
Personal history of cancer
 Yes 10 (10%) Perceived physical health 3.50 2.00 3.75
Self-efficacy 3.67 3.17 3.83
Memory 2.75 1.75 2.75
(Continued)
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Table 3 (Continued)
n Variable Median Lower quartile Upper quartile P-values
anxiety 6.50 4.50 6.50
Body image 2.50 1.50 4.00
Cognitive closure 2.67 2.00 3.00
gsrh 2.50 2.00 2.75 0.07
sexual life 3.00 3.00 4.00
 no 90 (90%) Perceived physical health 2.75 2.13 3.38
Self-efficacy 2.83 2.17 3.67
Memory 1.75 1.25 2.50
anxiety 5.50 4.00 7.00
Body image 2.00 1.50 3.00
Cognitive closure 3.00 2.33 4.00
gsrh 2.00 1.50 2.50
sexual life 3.00 2.00 4.00
age
 #40 years 15 Perceived physical health 3.00 1.75 3.75
Self-efficacy 3.00 2.00 3.67
Memory 2.00 1.25 3.50
anxiety 5.00 2.50 6.50
Body image 2.00 1.50 2.50
Cognitive closure 2.67 2.00 3.33 0.02
gsrh 2.00 1.50 2.50
sexual life 3.00 2.50 4.00
 50 years 29 Perceived physical health 2.75 2.38 3.50
Self-efficacy 3.17 2.00 3.67
Memory 2.00 1.50 2.50
anxiety 5.00 4.00 6.50
Body image 2.50 1.50 3.50
Cognitive closure 2.67 2.00 3.33
gsrh 2.00 1.25 2.50
sexual life 3.00 2.00 3.50
 60 years 35 Perceived physical health 2.88 2.00 3.38
Self-efficacy 2.67 2.17 3.50
Memory 1.63 1.25 2.50
anxiety 6.00 4.50 7.00
Body image 2.00 1.00 3.00
Cognitive closure 3.33 2.67 4.00
gsrh 2.00 1.50 2.75
sexual life 3.00 2.00 4.00
 $70 years 20 Perceived physical health 2.75 2.44 3.50
Self-efficacy 2.92 2.42 3.83
Memory 1.63 1.00 2.63
anxiety 6.25 3.50 7.75
Body image 2.00 1.00 3.00
Cognitive closure 2.83 2.33 4.33
gsrh 1.88 1.25 2.88
sexual life 3.00 1.50 4.00
Abbreviation: gsrh, global self-rated health.
too difficult to complete or burdensome. Moreover, patients 
showed a clear preference for completing the questionnaire on 
the iPad, compared to the paper-and-pencil version, regard-
less of their age and educational level. These are encouraging 
and important data, considering that the electronic version 
is necessary for the future development of the tool, which 
will automatically generate the patient’s profile to be sent 
to physicians, perhaps in the form of a graphic report, to 
help them to have an immediate insight into the patient’s 
characteristics.
From a statistical point of view, the ALGA-BC scale 
shows significant evidence of validity and reliability. The 
item-total correlations for the total scale is high. This indi-
cates that the 29 items included in the eight key factors 
measure the same concept and that none of them fulfilled 
the criteria for removal. These findings are confirmed by the 
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Table 4 Comparison between patients and healthy subjects
Variable Median Lower  
quartile
Upper  
quartile
P-values
Cases (n=100)
 Physical state 2.9 2.1 3.4 0.0003
 Self-efficacy 3.0 2.2 3.7 ,0.0001
 Memory-attention 1.8 1.3 2.5 0.197
 Body image 2.0 1.5 3.0 0.751
 Cognitive closure 3.0 2.0 3.7 ,0.0001
 gsrh 2.0 1.5 2.8 ,0.0001
 sexual life 3.0 2.0 4.0 0.002
 anxiety 2.0 1.3 3.0 ,0.0001
 rumination 5.5 4.0 7.0 0.017
Controls (n=730)
 Physical state 2.5 2.0 3.0
 Self-efficacy 2.2 2.0 2.5
 Memory-attention 2.0 1.5 2.5
 Body image 2.0 1.5 3.0
 Cognitive closure 3.3 3.0 4.0
 gsrh 1.5 1.0 2.0
 sexual life 2.5 2.0 3.0
 anxiety 3.5 2.0 5.0
 rumination 1.7 1.3 2.7
Abbreviation: gsrh, global self-rated health.
CFAs. The CFA analyses show that the eight-factor model 
has strong factor loadings and satisfactory goodness-of-fit 
values.
In terms of psychometric characteristics, this first evalua-
tion suggests that the ALGA-BC questionnaire is a promising 
instrument for breast cancer patient profiling. In fact, even if 
the authors are aware that the ALGA-BC questionnaire does 
not completely cover all the patients’ needs and concerns, the 
eight factors that emerged from the factor analysis represent 
the critical areas that are useful for physicians’ understanding 
of the patients’ strengths and weaknesses in order to personal-
ize their interaction and communication style. In particular, 
the “global self-rated health” and the “perceived physical 
health” factors are useful for understanding how the patient 
perceives and judges her health and how she reports her physi-
cal symptoms, giving the oncologist important information 
that completes the objective clinical evaluation. The factors 
“anxiety” and “self efficacy” indicate whether the patient 
tends to be psychologically overwhelmed by the disease and 
if she shows adequate self-confidence in her coping abilities 
when confronted with life stressors such as the diagnosis of 
cancer. “Cognitive closure” informs the physician about the 
amount of information the patient wishes to receive about ill-
ness and treatment, while “memory” indicates if patients are 
able (or feel able) to remember a lot of input or not. Finally, 
even if it appears as a separate factor only in the healthy 
subjects sample, the factor “rumination” strongly indicates 
that patients are more prone than controls to focus attention 
on negative thoughts, instead of searching for positive solu-
tions. Such information will help the physician to approach 
the patient according to her needs and preferences, taking 
into account her difficulties and limitations in order to not 
overload her with unsuitable or counterproductive data. The 
last two factors (“body image” and “sexual life”) are par-
ticularly important when a diagnosis of breast cancer occurs 
and need to be taken into account by physicians, who should 
be responsible not only for treating the disease, but also for 
treating the patient as an individual with specific (and often 
very relevant) needs and worries.
Regarding the observed influences of the sociodemo-
graphic variables, at least on some of the eight factors, 
they must be taken into account when generating the single 
patient’s profile. In particular, it appears that patients with 
a high educational level consider their health status better 
than those with lower education. We cannot exclude that 
the association between “educational level” and “perceived 
physical health” scores may reflect real differences in health, 
and not just the subjects’ perceptions of their physical condi-
tions. Nevertheless, a possible explanation is that, regardless 
of the real differences in health among them, the patients’ 
knowledge about treatment options makes them more opti-
mistic about their health status.
Being mothers makes patients more vulnerable to anxiety, 
presumably because of the worry related to the children’s 
care. A previous or current psychological treatment is related 
to increased anxiety, worse body image perception, and a 
decrease in memory (that is also common in different psy-
chological disturbances), while, when women experience a 
diagnosis of cancer for the second time, they tend to consider 
their global health better than patients who are at their first 
diagnosis, probably because they have already experienced 
similar symptoms in the past. Finally, older patients tend to 
show higher cognitive closure than younger patients, indi-
cating that they need more time and more information when 
they have to make a decision.
Comparing breast cancer patients with healthy subjects, 
we observed that patients show worse perceived physical 
health and sexual life, lower self-efficacy, higher cognitive 
closure, and higher rumination than healthy subjects. These 
expected differences confirm that the ALGA questionnaire 
is a good instrument for discriminating between cancer 
patients and healthy subjects, at least on the examined 
variables.
This approach, based on patient profiling, is supposed 
to improve the patient–physician relationship as well as the 
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patient’s compliance, and to increase her participation in 
the medical decision making. Moreover, this information 
is also an important predictor of the patient’s future qual-
ity of life and health, being related to the way in which the 
patient copes with the disease. With the help of ALGA-BC, 
oncologists are recommended to put their attention on the 
mental effects of the disease or treatment and eventually 
recommend the patient to refer to other specialists to cope 
with them. 
Obviously, ALGA-BC is not intended to provide an 
exhaustive psychological diagnosis nor to assess the presence 
of psychiatric disorders that are usually assessed against the 
“gold standard” of diagnosis by interview or, as second best, 
against a proxy gold standard of another questionnaire which 
has proven itself for this purpose, but to generally evaluate 
physical, psychological, and cognitive reactions related to 
breast cancer. In our opinion, such a kind of assessment is 
an important step in achieving real personalized care for 
cancer patients that overcomes the limitations imposed by a 
purely biological and genetic approach.43 Cancer is increas-
ingly prevalent, being a strain on the health care system and 
a source of significant impairment for patients. This evidence 
highlights the public health magnitude of cancer and the 
importance of efforts to characterize and address the health 
concerns of cancer patients. Cancer experience is a complex 
phenomenon that impacts all aspects of the patient’s life, 
including her physical, emotional, and psychological health,44 
as shown by the fact that cancer patients and healthy subjects 
obtained significantly different scores in most of the factors. 
However, to date, there are no available, easy-to-use tools 
that directly help oncologists to understand such effects or 
how they can be different from one patient to the others. Not 
surprisingly, the need for developing the ALGA-BC question-
naire (and the related tool, which is now being developed in 
our lab) arose from clinical oncologists who expressed their 
difficulties in finding an efficient way to interact with their 
patients, especially during the first encounter, being pressed 
by time constraints that is often not fully understood or mis-
interpreted by the patients themselves.  
Of course, the present study presents some limitations. 
First of all, some psychometric properties such as the respon-
siveness or sensitivity to change of the questionnaire were not 
studied. Such properties are important and must be investi-
gated in another study. Moreover, some statistical methods 
such as principal component analysis need a lot of patients 
to be realized: so the psychometric properties of the final 
questionnaire (with the 29 items retained) should be studies 
in further studies with an adequate sample size. Finally, to 
assess the criterion validity, and to verify the accuracy of 
the instrument, results obtained by the ALGA questionnaire 
should be compared with those obtained by other validated 
questionnaires. This step has not been yet conducted due to 
the difficulty of asking patients to complete more than one 
questionnaire before their encounter with the physician and 
must be included in future studies.
Conclusion
Considering the increasing incidence of cancer worldwide, 
the limits imposed by health care systems regarding the time 
physicians can spend with their patients, and the need to 
provide improved patient care, this study provides a validated 
questionnaire that allows personalization of the medical 
approach that takes into account the patient’s physical and 
mental aspects, as well as the purely genetic and clinical ones. 
The ALGA-BC questionnaire is valid, reliable, and able to 
find out psychological alterations in breast cancer patients. 
For these reasons, we argue that it can be included in new 
decision support tools for physicians, to assist both in clinical 
practice and research.
Acknowledgment
This work was supported by the European Union ICT 
Program (Project “p-medicine – from data sharing and 
integration via VPH models to personalized medicine” FP7-
ICT-2009.5.3).
Disclosure
The authors report no conflicts of interest in this work.
References
1. Aspinall MG, Hamermesh RG. Realizing the promise of personalized 
medicine. Harv Bus Rev. 2007;85(10):108–117, 165.
2. Peppercorn JM, Smith TJ, Helft PR, et al; American Society of Clinical 
Oncology. American society of clinical oncology statement: toward 
individualized care for patients with advanced cancer. J Clin Oncol. 
2011;29(6):755–760.
3. Epstein RM, Franks P, Fiscella K, et al. Measuring patient-centered com-
munication in patient-physician consultations: theoretical and practical 
issues. Soc Sci Med. 2005;61(7):1516–1528.
4. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-
related quality-of-life assessments and patient-physician communication: 
a randomized controlled trial. JAMA. 2002;288(23): 3027–3034.
5. Trudel JG, Leduc N, Dumont S. Perceived communication between 
physicians and breast cancer patients as a predicting factor of patients’ 
health-related quality of life: a longitudinal analysis. Psychooncology. 
2014;23(5):531–538.
6. Citrin DL, Bloom DL, Grutsch JF, Mortensen SJ, Lis CG. Beliefs and 
perceptions of women with newly diagnosed breast cancer who refused 
conventional treatment in favor of alternative therapies. Oncologist. 
2012;17(5):607–612.
7. Rattray J, Jones MC. Essential elements of questionnaire design and 
development. J Clin Nurs. 2007;16(2):234–243.
Breast Cancer: Targets and Therapy
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/breast-cancer---targets-and-therapy-journal
Breast Cancer: Targets and Therapy is an international, peer- 
reviewed open access journal focusing on breast cancer research, 
identification of therapeutic targets and the optimal use of preven-
tative and integrated treatment interventions to achieve improved 
outcomes, enhanced survival and quality of life for the cancer patient. 
View the full aims and scopes of this journal here. The manuscript 
management system is completely online and includes a very quick 
and fair peer-review system, which is all easy to use. Visit http://
www.dovepress.com/testimonials.php to read real quotes from 
published authors.
Breast Cancer: Targets and Therapy 2015:7submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
146
gorini et al
 8. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed 
for measurement properties of health status questionnaires. J Clin 
Epidemiol. 2007;60(1):34–42.
 9. Aaronson NK, Ahmedzai S, Bergman B, et al. The European 
 Organization for Research and Treatment of Cancer QLQ-C30: 
a quality-of-life instrument for use in international clinical trials in 
 oncology. J Natl Cancer Inst. 1993;85(5):365–376.
 10. Sprangers MA, Groenvold M, Arraras JI, et al. The European 
 Organization for Research and Treatment of Cancer breast cancer-
specific quality-of-life questionnaire module: first results from a three-
country field study. J Clin Oncol. 1996;14(10):2756–2768.
 11. Radloff LS. The CES-D scale: a self-report depression scale for research 
in the general population. Appl Psychol Meas. 1977;1:385–401.
 12. Royle J, Lincoln NB. The Everyday Memory Questionnaire-revised: 
development of a 13-item scale. Disabil Rehabil. 2008;30(2): 
114–121.
 13. Schwarzer R, Jerusalem M, Weinman J, Wright S, Johnston M. 
 Generalized self-efficacy scale. In: Measures in Health Psychology: 
A User’s Portfolio. Windsor: Nfer-Nelson; 1995:35–37.
 14. Kruglanski AW, Atash MN, DeGrada E, Mannetti L, Pierro A, Webster DM. 
Psychological theory testing versus psychometric nay-saying: comment 
on Neuberg et al’s (1997) critique of the need for closure scale. J Pers 
Soc Psychol. 1997;73(5):1005–1016; discussion 1017–1029.
 15. Polit DF, Beck CT. The content validity index: are you sure you know 
what’s being reported? Critique and recommendations. Res Nurs Health. 
2006;29(5):489–497.
 16. Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of 
content validity? Appraisal and recommendations. Res Nurs Health. 
2007;30(4):459–467.
 17. Kane M. Current concerns in validity theory. Journal of Educational 
Measurement. 2001;38:319–342.
 18. DeVon HA, Block ME, Moyle-Wright P, et al. A psychometric tool-
box for testing validity and reliability. J Nurs Scholarsh. 2007;39(2): 
155–164.
 19. Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ. Evaluating the 
use of exploratory factor analysis in psychological research. Psychol 
Methods. 1999;4:272–299.
 20. Horn JL. A rationale and test for the number of factors in factor analysis. 
Psychometrika. 1965;30:179–185.
 21. Zwick WR, Velicer WF. Comparison of five rules for determining the 
number of components to retain. Psychol Bull. 1986;99:432–442.
 22. Guilford JP. Factor analysis in a test-development program. Psychol 
Rev. 1948;55:79–94.
 23. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure 
analysis: conventional criteria versus new alternatives. Struct Equ 
Modeling. 1999;6(1):1–55.
 24. Bartlett MS. Properties of sufficiency and statistical tests. Proceedings 
of the Royal Statistical Society. 1937;Series A 160:268–282.
 25. Snedecor GW, Cochran WG. Statistical Methods. 8th ed. Ames: Iowa 
State University Press; 1989.
 26. DeSalvo KB, Fisher WP, Tran K, Bloser N, Merrill W, Peabody J. 
Assessing measurement properties of two single-item general health 
measures. Qual Life Res. 2006;15(2):191–201.
 27. Shadbolt B, Barresi J, Craft P. Self-rated health as a predictor of 
survival among patients with advanced cancer. J Clin Oncol. 2002; 
20(10):2514–2519.
 28. Taylor N, Absolom K, Snowden J, Eiser C; Late Effects Group  Sheffield. 
Need for psychological follow-up among young adult survivors of 
childhood cancer. Eur J Cancer Care (Engl). 2012;21(1):52–58.
 29. Arden-Close E, Absolom K, Greenfield DM, Hancock BW, Coleman RE, 
Eiser C; Late Effects Group Sheff ield. Gender differences in 
 self-reported late effects, quality of life and satisfaction with clinic in 
survivors of lymphoma. Psychooncology. 2011;20(11):1202–1210.
 30. Spielberger CD, Gorssuch RL, Lushene PR, Vagg PR, Jacobs GA. 
Manual for the State-Trait Anxiety Inventory. Consulting Psychologists 
Press, Inc.; 1983.
 31. Patrick DL, Ferketich SL, Frame PS, et al; National Institutes of Health 
State-of-the-Science Panel. National Institutes of Health State-Of-The-
Science Conference Statement: symptom management in cancer: pain, 
depression, and fatigue, July 15–17, 2002. J Natl Cancer Inst Monogr. 
2004;(32):9–16.
 32. Singer S, Das-Munshi J, Brähler E. Prevalence of mental health condi-
tions in cancer patients in acute care – a meta-analysis. Ann Oncol. 
2010;21(5):925–930.
 33. Cheng KK, Yeung RM. Impact of mood disturbance, sleep disturbance, 
fatigue and pain among patients receiving cancer therapy. Eur J Cancer 
Care (Engl). 2013;22(1):70–78.
 34. Schwarzer R, Scholz U. Cross-cultural assessment of coping resources: 
the general perceived self-efficacy scale. Presented at: Asian Congress 
of Health Psychology; August 28–29, 2000; Tokyo.
 35. Bandura A. Self-Efficacy: The Exercise of Control. New York: Freeman; 
1997.
 36. Schwarzer R, editor. Self-Efficacy: Thought Control of Action. 
 Washington, DC: Hemisphere; 1992.
 37. Shiloh S, Koren S, Zakay D. Individual differences in compensatory 
decision-making style and need for closure as correlates of subjec-
tive decision complexity and difficulty. Pers Individ Dif. 2001;30(4): 
699–710.
 38. Webster DM, Kruglanski AW. Individual differences in need for cogni-
tive closure. J Pers Soc Psychol. 1994;67(6):1049–1062.
 39. Berman MG, Askren MK, Jung M, et al. Pretreatment worry and neu-
rocognitive responses in women with breast cancer. Health Psychol. 
2014;33(3):222–231.
 40. Klepin HD, Geiger AM, Bandos H, et al. Cognitive factors associated 
with adherence to oral antiestrogen therapy: results from the cognition 
in the study of tamoxifen and raloxifene (Co-STAR) study. Cancer 
Prev Res (Phila). 2014;7(1):161–168.
 41. Morone G, Iosa M, Fusco A, et al. Effects of a multidisciplinary edu-
cational rehabilitative intervention in breast cancer survivors: the role 
of body image on quality of life outcomes. Scientific World Journal. 
2014;2014:451935.
 42. Alacacioglu A, Ulger E, Varol U, et al. Depression, anxiety and sexual 
satisfaction in breast cancer patients and their partners-Izmir oncology 
group study. Asian Pac J Cancer Prev. 2014;15(24):10631–10636.
 43. Gorini A, Pravettoni G. P5 medicine: a plus for a personalized approach 
to oncology. Nat Rev Clin Oncol. 2011;8(7):444.
 44. Council NR. Cancer Care for the Whole Patient: Meeting Psychosocial 
Health Needs. Washington: The National Academies Press; 2008.
